Drug choices reviewed for benign prostatic hyperplasia
Lisa Selwood
Abstract
Lisa Selwood
Abstract
Benign prostatic hyperplasia (BPH) is a common condition affecting men aged ≥ 40 years, and the incidence increases with age. The association between BPH and lower urinary tract symptoms (LUTS) is well elucidated. This review will focus on treatment options for BPH.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Benign prostatic hyperplasia (BPH) is a common condition affecting men aged ≥ 40 years, and the incidence increases with age. The association between BPH and lower urinary tract symptoms (LUTS) is well elucidated. This review will focus on treatment options for BPH.
Key concepts: Medicine, Lower urinary tract symptoms, Hyperplasia, Urology, Incidence (geometry), Drug, Prostate, Gynecology